NextCure, Inc.NXTCNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P38
Within normal range
vs 3Y Ago
-3.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-21.59%
202422.97%
20231.69%
20225.87%
2021-27.34%
2020-26.19%
2019-545.73%
2018163.86%
20170.00%